Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome
- PMID: 7848393
- DOI: 10.1001/archsurg.1994.01420270094020
Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome
Abstract
Objective: To evaluate the effects of gender on prognostic outcome of patients with melanoma.
Design: Retrospective cohort study, including 20 years of follow-up.
Setting: Duke University Melanoma Clinic, Durham, NC, a referral center for patients with melanoma.
Patients: Patients with melanoma (N = 6383), consisting of 45% females and 55% males, obtained from a referred sample. Eligibility requirements were nonocular melanomas and white race.
Main outcome measures: Time to metastases and survival.
Results: Females with melanoma demonstrated a superior prognostic outcome over males, with a 34% survival advantage and a 28% disease-free advantage. When each of the variables of age, site, Clark's level, histologic type, and tumor thickness was explored for possible influences on prognostic outcome, female survival advantage persisted, although modified by independent variables. The greatest influence came from the variables of site, Clark's level, and Breslow's thickness. Age, specifically in premenopausal vs postmenopausal age groups, was not significant in altering females' prognostic advantage. A multivariate analysis combining the effects of all the variables resulted in females still maintaining a 22% survival advantage and a 17% disease-free advantage.
Conclusions: Females with melanoma have a significant prognostic advantage over their male counterparts that cannot be fully explained by influences from the variables of age, site, Clark's level, histology, and Breslow's thickness. This superior prognostic outcome does not appear to be associated with menstrual status. Evidence does suggest that the protective factor for females occurs at the level of metastases.
Comment in
-
Survival superiority of females with melanoma.Arch Surg. 1994 Dec;129(12):1343-4. doi: 10.1001/archsurg.1994.01420360133019. Arch Surg. 1994. PMID: 7986167 No abstract available.
Similar articles
-
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.Ann Surg. 1978 Dec;188(6):732-42. doi: 10.1097/00000658-197812000-00004. Ann Surg. 1978. PMID: 736651 Free PMC article.
-
Treatment Outcome and Prognostic Factors for Malignant Skin Melanoma Treated with Radical Surgery.Asian Pac J Cancer Prev. 2015;16(14):5709-14. doi: 10.7314/apjcp.2015.16.14.5709. Asian Pac J Cancer Prev. 2015. PMID: 26320440
-
Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital.J Med Assoc Thai. 2015 Aug;98(8):820-7. J Med Assoc Thai. 2015. PMID: 26437541
-
Influence of gender on survival in patients with stage I malignant melanoma.J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):429-40. doi: 10.1016/0190-9622(92)70068-q. J Am Acad Dermatol. 1992. PMID: 1564150 Review.
-
Pathological staging of melanoma.Methods Mol Biol. 2014;1102:325-51. doi: 10.1007/978-1-62703-727-3_17. Methods Mol Biol. 2014. PMID: 24258986 Review.
Cited by
-
Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.J Am Acad Dermatol. 2016 Oct;75(4):698-705. doi: 10.1016/j.jaad.2016.05.011. Epub 2016 Jul 16. J Am Acad Dermatol. 2016. PMID: 27436155 Free PMC article.
-
In vitro effect of progesterone on human melanoma (BLM) cell growth.Int J Clin Exp Med. 2014 Nov 15;7(11):3941-53. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25550902 Free PMC article.
-
Sex Differences in Melanoma.Curr Epidemiol Rep. 2019 Jun;6(2):112-118. doi: 10.1007/s40471-019-00192-7. Epub 2019 May 31. Curr Epidemiol Rep. 2019. PMID: 32855900 Free PMC article.
-
The epidemiology of melanoma in young adults.Expert Rev Dermatol. 2013;8(6):707-716. doi: 10.1586/17469872.2013.844465. Expert Rev Dermatol. 2013. PMID: 40129654 Free PMC article.
-
Association of sentinel lymph node biopsy with survival for head and neck melanoma: survival analysis using the SEER database.JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1101-9. doi: 10.1001/jamaoto.2014.2530. JAMA Otolaryngol Head Neck Surg. 2014. PMID: 25321889 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical